SIROLLI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 6.340
EU - Europa 3.333
AS - Asia 3.288
Continente sconosciuto - Info sul continente non disponibili 908
SA - Sud America 340
AF - Africa 56
OC - Oceania 13
Totale 14.278
Nazione #
US - Stati Uniti d'America 6.179
SG - Singapore 1.229
CN - Cina 970
IT - Italia 621
IE - Irlanda 485
UA - Ucraina 456
SE - Svezia 365
RU - Federazione Russa 344
TR - Turchia 335
GB - Regno Unito 316
VN - Vietnam 282
BR - Brasile 265
DE - Germania 246
FR - Francia 223
IN - India 212
FI - Finlandia 107
CA - Canada 105
HK - Hong Kong 68
BD - Bangladesh 53
NL - Olanda 32
PL - Polonia 31
JP - Giappone 26
AR - Argentina 24
MX - Messico 21
BE - Belgio 20
ES - Italia 20
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
AT - Austria 14
IQ - Iraq 13
AU - Australia 12
EC - Ecuador 12
ID - Indonesia 11
IR - Iran 11
CO - Colombia 9
EG - Egitto 9
IL - Israele 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
KR - Corea 7
LT - Lituania 7
PK - Pakistan 7
VE - Venezuela 7
CL - Cile 6
EU - Europa 6
PY - Paraguay 6
DZ - Algeria 5
HN - Honduras 5
JO - Giordania 5
NP - Nepal 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BO - Bolivia 4
CR - Costa Rica 4
GT - Guatemala 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
MY - Malesia 4
NO - Norvegia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BB - Barbados 3
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
PA - Panama 3
TN - Tunisia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
CY - Cipro 2
DM - Dominica 2
ET - Etiopia 2
HR - Croazia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
SN - Senegal 2
SO - Somalia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GD - Grenada 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 13.372
Città #
Singapore 850
San Jose 654
Ashburn 580
Chandler 522
Jacksonville 515
Dublin 483
Houston 334
Dallas 303
Beijing 260
Council Bluffs 248
Los Angeles 226
Princeton 209
Southend 206
New York 162
Izmir 160
Nanjing 142
Chieti 139
Dearborn 125
Santa Clara 103
Ho Chi Minh City 86
Wilmington 82
Cambridge 81
Ann Arbor 77
Nanchang 75
San Francisco 69
The Dalles 65
Altamura 64
Hong Kong 62
Tongling 60
Phoenix 56
Orem 55
Hanoi 54
Buffalo 52
Denver 46
Boardman 43
Munich 42
Atlanta 40
São Paulo 38
Woodbridge 35
Moscow 34
Brooklyn 33
Washington 33
Hebei 32
Shenyang 32
Montreal 31
Dong Ket 30
Milan 29
Kunming 27
Warsaw 26
Chicago 25
Pescara 25
Tianjin 25
London 24
Redondo Beach 23
Tokyo 23
Boston 21
Jiaxing 21
Rome 20
Nuremberg 19
Ottawa 19
Brussels 18
Changsha 18
Helsinki 18
Stockholm 18
Brno 17
Hefei 17
Jinan 17
Kocaeli 17
Amsterdam 16
Poplar 16
Chennai 15
Düsseldorf 15
Seattle 15
Toronto 15
Da Nang 13
Haiphong 13
Hangzhou 13
Johannesburg 13
Norwalk 13
Paris 12
San Mateo 12
Shanghai 12
Augusta 11
Bologna 11
Leawood 11
Manchester 11
Naples 11
Zhengzhou 11
Ardabil 10
Bari 10
Columbus 10
Ningbo 10
Rio de Janeiro 10
Catania 9
Frankfurt am Main 9
Vancouver 9
Vienna 9
Cairo 8
Guangzhou 8
Las Vegas 8
Totale 8.464
Nome #
Treatment options for anemia in kidney transplant patients: a review 1.151
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 460
Quali soluzioni future per la dialisi peritoneale? 242
Plasma protein carbonylation in chronic uremia 204
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 198
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 189
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 183
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 178
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 175
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 175
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 170
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 169
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 164
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 163
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 160
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 160
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 158
Proteomics characterization of protein adsorption onto hemodialysis membranes 154
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 153
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 151
Proteomic Investigations into Hemodialysis Therapy 151
Biocompatibility of DIAPES 150
Examining hemodialyzer membrane performance using proteomic technologies 147
Effect of erythropoietin on primed leucocyte expression profile. 147
In vitro microbiology studies on a new peritoneal dialysis connector 145
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 144
Urinary Peptidomic Biomarkers in Kidney Diseases 144
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 141
Blood cell proteomics in chronic kidney disease 140
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 137
Update sull'impiego della proteomica in emodialisi 135
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 135
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 134
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 134
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 131
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 128
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 128
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 127
Removal of uremic plasma factors using different dialysis modalities 125
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 125
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 125
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 124
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 123
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 122
Proteomic analysis of protein adsorption onto haemodialysis membranes 122
Uremic toxicity and anemia 121
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 121
Use of oral hypoglycemic agents in patients with chronic kidney failure 121
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 121
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 121
Vascular inflammation in end-stage renal disease: the red blood cell connection 119
L-carnitine in uremic anemia 118
New treatment approaches for the anemia of CKD 117
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 116
Glomerulopathies associated with psoriasis: a report of three cases 116
Association of chronic microinflammation, progression of atherosclerosis and outcome in maintenance hemodialysis (HD): long term effect of dialytic membranes 114
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study 111
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations 111
Management of IgA nephropathy 110
Approccio diagnostico al sanguinamento gastrointestinale occulto nel paizente in trattamento emodialitico 110
L'angiodisplasia gastroenterica nel paziente uremico in trattamento emodialitico regolare. Due casi clinici 108
Hypercoagulability in uraemia: role of increased surface exposure of phosphatidylserine on erythrocytes 107
Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis 106
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine 104
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability 104
Do haemodialysis membranes influence atherosclerosis? A one-year prospective study 102
Increased adhesion of uraemic red blood cells to vascular endothelium causes reduction of endothelial nitric oxide synthase expression 101
Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge 100
L’accesso vascolare negli anziani: prevenzione o spreco di risorse? 99
Malattie renali cistiche 99
Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review 99
Utilità di uno screening urinario in età scolastica 97
Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis B infection: A case report 96
Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes 96
Proteomics and nephrology 96
Pro-atherogenic effect of uraemic red blood cell (RBC): role of RBC surface-exposed phosphatidylserine 96
null 96
Interactions between platelets and leukocytes during hemodialysis 95
Pro-inflammatory effects of erythrocytes from uremic patients on cultured human endothelial cells: insights into the signaling pathways 95
Nefropatie glomerulari familiari ed ereditarie 95
Rene e paraproteine 95
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. 94
Surface Antigen Expression and Platelet Neutrophil Interactions in Haemodialysis 93
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 93
Prognosis of CKD patients receiving outpatient nephrology care in Italy 93
L-carnitine may decrease platelet activation response with phosphatidylserine exposure in chronic uraemia 93
Use of Proton Pump Inhibitors Is Not Associated with Post-Dialysis Fatigue and Time of Recovery after Dialysis in Patients on Maintenance Hemodialysis 91
Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients 91
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? 91
Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist 90
Rene e Gravidanza 90
Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review 88
L’uremia batte…dove il dente duole!!! 86
Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia 84
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care 80
Intensity, Duration, and Frequency of Post‐Dialysis Fatigue in Patients on Chronic Haemodialysis 80
null 79
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia 75
null 74
Post-dialysis fatigue and survival in patients on chronic hemodialysis 69
Totale 13.588
Categoria #
all - tutte 54.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022508 0 0 9 120 31 8 21 28 51 36 47 157
2022/20231.502 139 191 87 156 133 267 89 114 222 15 50 39
2023/2024812 59 20 58 32 41 280 167 30 4 20 19 82
2024/20251.762 114 246 203 90 46 71 43 84 264 74 223 304
2025/20264.926 333 158 331 443 374 207 717 213 416 371 1.243 120
2026/2027326 63 167 96 0 0 0 0 0 0 0 0 0
Totale 14.278